Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 25

1.

The STAT3 Inhibitor Galiellalactone Reduces IL6-Mediated AR Activity in Benign and Malignant Prostate Models.

Handle F, Puhr M, Schaefer G, Lorito N, Hoefer J, Gruber M, Guggenberger F, Santer FR, Marques RB, van Weerden WM, Claessens F, Erb HHH, Culig Z.

Mol Cancer Ther. 2018 Dec;17(12):2722-2731. doi: 10.1158/1535-7163.MCT-18-0508. Epub 2018 Sep 25.

PMID:
30254184
2.

Tumor heterogeneity, aggressiveness, and immune cell composition in a novel syngeneic PSA-targeted Pten knockout mouse prostate cancer (MuCaP) model.

van Duijn PW, Marques RB, Ziel-van der Made ACJ, van Zoggel HJAA, Aghai A, Berrevoets C, Debets R, Jenster G, Trapman J, van Weerden WM.

Prostate. 2018 Sep;78(13):1013-1023. doi: 10.1002/pros.23659. Epub 2018 May 29.

PMID:
30133757
3.

Movember GAP1 PDX project: An international collection of serially transplantable prostate cancer patient-derived xenograft (PDX) models.

Navone NM, van Weerden WM, Vessella RL, Williams ED, Wang Y, Isaacs JT, Nguyen HM, Culig Z, van der Pluijm G, Rentsch CA, Marques RB, de Ridder CMA, Bubendorf L, Thalmann GN, Brennen WN, Santer FR, Moser PL, Shepherd P, Efstathiou E, Xue H, Lin D, Buijs J, Bosse T, Collins A, Maitland N, Buzza M, Kouspou M, Achtman A, Taylor RA, Risbridger G, Corey E.

Prostate. 2018 Dec;78(16):1262-1282. doi: 10.1002/pros.23701. Epub 2018 Aug 2.

PMID:
30073676
4.

Optical beam deflection sensor: design and experiments.

Sakamoto JMS, Marques RB, Kitano C, Rodrigues NAS, Riva R.

Appl Opt. 2017 Oct 1;56(28):8005-8013. doi: 10.1364/AO.56.008005.

PMID:
29047790
5.

α-Terpineol Induces Gastric Retention of Liquids by Inhibiting Vagal Parasympathetic Pathways in Rats.

da Silva MT, Marques RB, Batista-Lima FJ, Soares MA, Dos Santos AA, Magalhães PJ, de Assis Oliveira F, de Castro Almeida FR.

Planta Med. 2016 Oct;82(15):1329-1334. Epub 2016 Apr 28.

PMID:
27124242
6.

A novel long non-coding RNA in the rheumatoid arthritis risk locus TRAF1-C5 influences C5 mRNA levels.

Messemaker TC, Frank-Bertoncelj M, Marques RB, Adriaans A, Bakker AM, Daha N, Gay S, Huizinga TW, Toes RE, Mikkers HM, Kurreeman F.

Genes Immun. 2016 Mar;17(2):85-92. doi: 10.1038/gene.2015.54. Epub 2015 Dec 17.

PMID:
26673966
7.

High Efficacy of Combination Therapy Using PI3K/AKT Inhibitors with Androgen Deprivation in Prostate Cancer Preclinical Models.

Marques RB, Aghai A, de Ridder CMA, Stuurman D, Hoeben S, Boer A, Ellston RP, Barry ST, Davies BR, Trapman J, van Weerden WM.

Eur Urol. 2015 Jun;67(6):1177-1185. doi: 10.1016/j.eururo.2014.08.053. Epub 2014 Sep 12.

PMID:
25220373
8.

Mechanisms of the antinociceptive action of (-) epicatechin obtained from the hydroalcoholic fraction of Combretum leprosum Mart & Eic in rodents.

Lopes Lda S, Marques RB, Fernandes HB, Pereira Sda S, Ayres MC, Chaves MH, Almeida FR.

J Biomed Sci. 2012 Jul 25;19:68. doi: 10.1186/1423-0127-19-68.

9.

α-terpineol reduces mechanical hypernociception and inflammatory response.

de Oliveira MG, Marques RB, de Santana MF, Santos AB, Brito FA, Barreto EO, De Sousa DP, Almeida FR, Badauê-Passos D Jr, Antoniolli AR, Quintans-Júnior LJ.

Basic Clin Pharmacol Toxicol. 2012 Aug;111(2):120-5. doi: 10.1111/j.1742-7843.2012.00875.x. Epub 2012 Apr 11.

10.

Modulation of androgen receptor signaling in hormonal therapy-resistant prostate cancer cell lines.

Marques RB, Dits NF, Erkens-Schulze S, van Ijcken WF, van Weerden WM, Jenster G.

PLoS One. 2011;6(8):e23144. doi: 10.1371/journal.pone.0023144. Epub 2011 Aug 4.

11.

Antinociceptive effect on mice of the hydroalcoholic fraction and (-) epicatechin obtained from Combretum leprosum Mart & Eich.

Lopes LS, Marques RB, Pereira SS, Ayres MC, Chaves MH, Cavalheiro AJ, Vieira Júnior GM, Almeida FR.

Braz J Med Biol Res. 2010 Dec;43(12):1184-92.

12.

Bypass mechanisms of the androgen receptor pathway in therapy-resistant prostate cancer cell models.

Marques RB, Dits NF, Erkens-Schulze S, van Weerden WM, Jenster G.

PLoS One. 2010 Oct 19;5(10):e13500. doi: 10.1371/journal.pone.0013500.

13.

Genetic variation of the Fc gamma receptor 3B gene and association with rheumatoid arthritis.

Marques RB, Thabet MM, White SJ, Houwing-Duistermaat JJ, Bakker AM, Hendriks GJ, Zhernakova A, Huizinga TW, van der Helm-van Mil AH, Toes RE.

PLoS One. 2010 Oct 5;5(10). pii: e13173. doi: 10.1371/journal.pone.0013173.

14.

Antinociceptive effect of Zanthoxylum rhoifolium Lam. (Rutaceae) in models of acute pain in rodents.

Pereira SS, Lopes LS, Marques RB, Figueiredo KA, Costa DA, Chaves MH, Almeida FR.

J Ethnopharmacol. 2010 May 27;129(2):227-31. doi: 10.1016/j.jep.2010.03.009. Epub 2010 Mar 19.

PMID:
20304040
15.

TRAF1/C5 polymorphism is not associated with increased mortality in rheumatoid arthritis: two large longitudinal studies.

van Nies JA, Marques RB, Trompet S, de Jong Z, Kurreeman FA, Toes RE, Jukema JW, Huizinga TW, van der Helm-van Mil AH.

Arthritis Res Ther. 2010;12(2):R38. doi: 10.1186/ar2947. Epub 2010 Mar 5.

16.

Confirmation of STAT4, IL2/IL21, and CTLA4 polymorphisms in rheumatoid arthritis.

Daha NA, Kurreeman FA, Marques RB, Stoeken-Rijsbergen G, Verduijn W, Huizinga TW, Toes RE.

Arthritis Rheum. 2009 May;60(5):1255-60. doi: 10.1002/art.24503.

17.

Contribution of Fcgamma receptor IIIA gene 158V/F polymorphism and copy number variation to the risk of ACPA-positive rheumatoid arthritis.

Thabet MM, Huizinga TW, Marques RB, Stoeken-Rijsbergen G, Bakker AM, Kurreeman FA, White SJ, Toes RE, van der Helm-van Mil AH.

Ann Rheum Dis. 2009 Nov;68(11):1775-80. doi: 10.1136/ard.2008.099309. Epub 2008 Nov 19. Review.

PMID:
19019892
18.

Identification of a luteinizing hormone-selective determinant in the exodomain of a follicle-stimulating hormone receptor.

Vischer HF, Granneman JC, Koelink PJ, Marques RB, Bogerd J.

Gen Comp Endocrinol. 2008 May 1;156(3):490-8. doi: 10.1016/j.ygcen.2008.03.017. Epub 2008 Mar 25.

PMID:
18433752
19.

A candidate gene approach identifies the TRAF1/C5 region as a risk factor for rheumatoid arthritis.

Kurreeman FA, Padyukov L, Marques RB, Schrodi SJ, Seddighzadeh M, Stoeken-Rijsbergen G, van der Helm-van Mil AH, Allaart CF, Verduyn W, Houwing-Duistermaat J, Alfredsson L, Begovich AB, Klareskog L, Huizinga TW, Toes RE.

PLoS Med. 2007 Sep;4(9):e278. Erratum in: PLoS Med. 2007 Dec;4(12):e358.

20.

The human PC346 xenograft and cell line panel: a model system for prostate cancer progression.

Marques RB, van Weerden WM, Erkens-Schulze S, de Ridder CM, Bangma CH, Trapman J, Jenster G.

Eur Urol. 2006 Feb;49(2):245-57. Epub 2006 Jan 6. Review.

PMID:
16413664
21.

Androgen receptor modifications in prostate cancer cells upon long-termandrogen ablation and antiandrogen treatment.

Marques RB, Erkens-Schulze S, de Ridder CM, Hermans KG, Waltering K, Visakorpi T, Trapman J, Romijn JC, van Weerden WM, Jenster G.

Int J Cancer. 2005 Nov 1;117(2):221-9.

22.

Receptor-selective determinants in catfish gonadotropin seat-belt loops.

Vischer HF, Marques RB, Granneman JC, Linskens MH, Schulz RW, Bogerd J.

Mol Cell Endocrinol. 2004 Sep 30;224(1-2):55-63.

PMID:
15353180
23.

[Remuneration and productivity: the case of the Minas Gerais Hospital Foundation, Brazil, 1992-1995].

Cherchiglia ML, Girardi SN, Vieira Rde C, Marques RB, Mendes P, da Rocha W, Pereira LA.

Rev Panam Salud Publica. 1998 Aug;4(2):112-20. Spanish.

PMID:
9810430
24.

[Lipoprotein(a) concentrations in type I diabetes mellitus].

Figueroa AC, Gil RL, Pedragós AC, González GC, Marqués RB, Díaz JA, Llanos JO, Pérez AP.

Rev Clin Esp. 1996 Feb;196(2):87-91. Spanish.

PMID:
8685494
25.

[Artificial capillary kidney. Clinical experience with 220 hemodialysis].

Santino Filho F, Hoette M, Leal LC, Miranda EA, Biernat JC, Marques RB, Bou-Habib JC, Leite AM.

AMB Rev Assoc Med Bras. 1975 Apr;21(4):107-10. Portuguese. No abstract available.

PMID:
1088751

Supplemental Content

Loading ...
Support Center